Molecular and genetic aspects of odontogenic tumors: A review

Iranian Journal of Basic Medical Sciences

Volumn 18, Issue 6, 2015, Pages 529-536

  Garg, Kavita ^a   Chandra, Shaleen ^b   Raj, Vineet ^c   Fareed, Wamiq ^d   Zafar, Muhammad ^d  

^a Chandra Dental College   (India)

^b Saraswati Dental College and Hospital   (India)

^c KING GEORGE'S MEDICAL UNIVERSITY   (India)

^d TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Genes; Odontogenesis; Odontogenic tumors

Indexed keywords

EID: 84934287430     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Rajendran R. Shafer's textbook of oral pathology. India: Elsevier; 2009.
2. Regezi JA, Sciubba JJ, Jordan RC. Oral pathology: clinical pathologic correlations. Elsevier Health Sciences; 2012.
3. Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease, Professional Edition: Expert Consult‐Online. Elsevier Health Sciences; 2009.
4. Reichart P, Philipsen H, Sonner S. Ameloblastoma: biological profile of 3677 cases. Eur J Cancer Part B: Oral Oncol 1995; 31:86‐99.
5. Nakamura N, Mitsuyasu T, Higuchi Y, Sandra F, Ohishi M. Growth characteristics of ameloblastoma involving the inferior alveolar nerve: a clinical and histopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91:557‐562.
6. Becelli R, Carboni A, Cerulli G, Perugini M, Iannetti G. Mandibular ameloblastoma: analysis of surgical treatment carried out in 60 patients between 1977 and 1998. J Craniofac Surg 2002; 13:395‐400.
7. Stevens A, Lowe J. Pathology. New York: Mosbay; 2000.
8. Kumamoto H. Molecular pathology of odontogenic tumors. J Oral Pathol Med 2006; 35:65‐74.
9. Gazal G, Fareed WM, Zafar MS, Al-Samadani KH. Pain and anxiety management for pediatric dental procedures using various combinations of sedative drugs: A review. Saudi Pharm J 2014; Published ahead of print.
10. Cawson RA. Cawson's Essentials of Oral Pathology and Oral Medicine. 7th ed. Edinburgh: Churchill Livingstone; 2002.
11. Klein CA. Selection and adaptation during metastatic cancer progression. Nature 2013; 501:365‐372.
12. Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, Velculescu VE, et al. Genetic progression and the waiting time to cancer. PLoS Comput Biol 2007; 3:e225.
13. Michor F, Iwasa Y, Nowak MA. Dynamics of cancer progression. Nat Rev Cancer 2004; 4:197-205.
14. Kumamoto H, Ooya K. Expression of tumor necrosis factor a, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. J Oral Pathol Med 2005; 34:287-294.
15. Bishop JM. Molecular themes in oncogenesis. Cell 1991; 64:235-248.
16. Kumamoto H, Takahashi N, Ooya K. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas. J Oral Pathol Med 2004; 33:360-367.
17. Kumamoto H, Ooya K. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas. J Oral Pathol Med 2005; 34:565-572.
18. Kumamoto H, Izutsu T, Ohki K, Takahashi N, Ooya K. p53 gene status and expression of p53, MDM2, and p14ARF proteins in ameloblastomas. J Oral Pathol Med 2004; 33:292-299.
19. Kumamoto H, Ohki K, Ooya K. Expression of p63 and p73 in ameloblastomas. J Oral Pathol Med 2005; 34:220-226.
20. Kumamoto H, Kimi K, Ooya K. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. J Oral Pathol Med 2001; 30:596-602.
21. Wunder JS, Czitrom AA, Kandel R, Andrulis IL. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas. J Natl Cancer Inst 1991; 83:194-200.
22. Benedict WF, Murphree AL, Banerjee A, Spina CA, Sparkes MC, Sparkes RS. Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science 1983; 219:973-975.
23. Castrilli G, Piantelli M, Artese L, Perfetti G, Rubini C, Fioroni M, et al. Expression of hMSH2 and hMLH1 proteins of the human DNA mismatch repair system in ameloblastoma. J oral path & med 2001; 30:305-308.
24. Mork J, Lie AK, Glattre E, Clark S, Hallmans G, Jellum E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344:1125-1131.
25. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14:467-475.
26. Sand L, Jalouli J, Larsson P, Magnusson B, Hirsch J. Presence of human papilloma viruses in intraosseous ameloblastoma. J Oral Maxillofac Surg 2000; 58:1129-1134.
27. Eberhart CG, Argani P. Wnt signaling in human development: beta-catenin nuclear translocation in fetal lung, kidney, placenta, capillaries, adrenal, and cartilage. Pediatri Dev Pathol 2001; 4:351-357.
28. Kumamoto H, Ooya K. Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors. Oral Dis 2006; 12:163-170.
29. So F, Daley TD, Jackson L, Wysocki GP. Immunohistochemical localization of fibroblast growth factors FGF-1 and FGF-2, and receptors FGFR2 and FGFR3 in the epithelium of human odontogenic cysts and tumors. J Oral Pathol Med 2001; 30:428-433.
30. Kumamoto H, Kinouchi Y, Ooya K. Telomerase activity and telomerase reverse transcriptase (TERT) expression in ameloblastomas. J Oral Pathol Med 2001; 30:231-236.
31. Allsopp RC, Weissman IL. Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? Oncogene 2002; 21:3270-3273.
32. Kumamoto H, Ooya K. Immunohistochemical detection of ß-catenin and adenomatous polyposis coli in ameloblastomas. J Oral Pathol Med 2005; 34:401-406.
33. Yamamoto K, Yoneda K, Yamamoto T, Ueta E, Osaki T. An immunohistochemical study of odontogenic mixed tumours. Eur J Cancer Part B: Oral Oncol 1995; 31:122-128.
34. Sekine J, Kitamura A, Ueno K, Sano K, Inokuchi T, Takahashi H, et al. Cell kinetics in mandibular ameloblastic fibro-odontoma evaluated by bromodeoxyuridine and proliferating cell nuclear antigen immunohistochemistry: case report. Br J Oral Maxillofac Surg 1996; 34:450-453.
35. Kumamoto H, Ooya K. Immunohistochemical and ultrastructural investigation of apoptotic cell death in granular cell ameloblastoma. J Oral Pathol Med 2001; 30:245-250.
36. Zafar MS, Ahmed N. Nano-mechanical evaluation of dental hard tissues using indentation technique. W App Sci J 2013; 28:1393-1399.
37. Kumamoto H. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 1997; 26:419-425.
38. Mitsuyasu T, Harada H, Higuchi Y, Kimura K, Nakamura N, Katsuki T, et al. Immunohistochemical demonstration of bcl-2 protein in ameloblastoma. J Oral Pathol Med 1997; 26:345-358.
39. Kumamoto H, Ohki K, Ooya K. Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas. J Oral Pathol Med 2004; 33:185-190.
40. Sauk JJ, Nikitakis NG, Scheper MA. Are we on the brink of nonsurgical treatment for ameloblastoma? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110:68-78.